Acorda Therapeutics (NASDAQ: ACOR)
Acorda Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Acorda Therapeutics Company Info
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
News & Analysis
Why Mindbody, New Gold, and Acorda Therapeutics Jumped Today
Even as the market fell again, these stocks posted gains. Find out why.
Here's Why Acorda Therapeutics Shares Sunk 15% Today
Wall Street is increasingly concerned about this biotech stock's future.
Here's Why Acorda Therapeutics Is Falling by Double Digits Today
Shares retreated after the company provided Wall Street with an updated regulatory timeline. Here's what investors need to know.
Why Brown-Forman, Acorda Therapeutics, and Energy XXI Gulf Coast Slumped Today
Find out which of these companies lost the most ground.
What's Behind Acorda Therapeutics Crashing 24.5% Today
The company could face stiff competition following an unfavorable ruling by an appeals court.
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
The company's lawyers made a last-ditch effort to save previously invalidated patents for a key drug.
Here's Why Acorda Therapeutics Inc. Stock Is Surging Today
An important player in the neuroscience field appears interested in acquiring the troubled drugmaker.
Here's Why Acorda Therapeutics Got Crushed Today
The company provided an update on one of its lead drug candidates.
Valuation
Earnings Transcripts
Acorda Therapeutics (ACOR) Q2 2019 Earnings Call Transcript
ACOR earnings call for the period ending June 30, 2019.
Acorda Therapeutics (ACOR) Q1 2019 Earnings Call Transcript
ACOR earnings call for the period ending March 31, 2019.
Acorda Therapeutics (ACOR) Q4 2018 Earnings Conference Call Transcript
ACOR earnings call for the period ending December 31, 2018.
Acorda Therapeutics Inc (ACOR) Q3 2018 Earnings Conference Call Transcript
ACOR earnings call for the period ending September 30, 2018.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.